Blog

AvidBiotics split forms CAR-T and antibiotic specialists – FierceBiotech


FierceBiotech

AvidBiotics split forms CART and antibiotic specialists
FierceBiotech
"We have developed a CART cell that is completely inert until it binds to a bispecific antibody, also developed by us, that we call a MicAbody," he tells FierceBiotech. The bispecific antibody activates the CART cell to then kill the targeted cancer

2017-11-01 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.